Peter Tsang
InvestorCo-Chief Investment Officer, Riverside Capital Appreciation Fund (RCAF) at The Riverside Company
About
Co-Chief Investment Officer of the Riverside Capital Appreciation Fund who led the Decera Clinical/Onviv deal for Riverside.
Colleagues at The Riverside Company
Anne Hayes
Capital Markets Senior Partner at The Riverside Company
Barron Fletcher
Associate at The Riverside Company
Grant Marcks
Partner, Origination at The Riverside Company
Jonathan Drillings
Principal at The Riverside Company
Mark Fishman
Principal at The Riverside Company
Peter Muncey
Vice President at The Riverside Company






